Uric Acid in vitro diagnostic test distributed without FDA clearance
DFI Co., Ltd. is recalling its Uric Acid in vitro diagnostic test (REF: 31H0P) because the devices were distributed without required FDA premarket clearance or approval.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is an FDA Class II device recall for distribution without premarket clearance. No illnesses, injuries, or device malfunctions are reported in the source text; the issue is regulatory compliance. Class II recalls without reported adverse events typically fall in the Moderate range per the rubric.
Plain-English summary
DFI Co., Ltd. is recalling the Uric Acid in vitro diagnostic test (REF: 31H0P) distributed in the United States, including Florida, Pennsylvania, and England. The devices were distributed without required FDA premarket clearance or approval.
The recalled lot numbers are 241023, 250415, 250509, 250617, and 250905. A total of 59,815 units have been distributed.
Consumers and healthcare providers who have these devices should contact DFI Co., Ltd. for further instructions on how to return or manage the recalled products. Laboratories using this test should cease using the recalled lots immediately.
The recalled product
- Product
- Uric Acid in vitro diagnostic test REF: 31H0P
- Manufacturer
- DFI Co., Ltd.
- Affected units
- 59,815
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- UDI: 08806141303077/ Lot: 241023
- 250415
- 250509
- 250617
- 250905
Distribution
Part of a larger recall action
This product is one of 7 recalled by DFI Co., Ltd. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · DFI Co., Ltd.
See all →- ModerateOne Step K in vitro diagnostic test recall for missing FDA clearance
FDA (Devices) · 2026-05-13
- ModerateOne Step pH In Vitro Diagnostic Test Recalled Without FDA Clearance
FDA (Devices) · 2026-05-13
- ModerateOne Step P in vitro diagnostic test lacks FDA premarket clearance
FDA (Devices) · 2026-05-13
- ModerateQUCARE Total Cholesterol in vitro Diagnostic Test Recalled
FDA (Devices) · 2026-05-13
- ModerateOne Step 10A In Vitro Diagnostic Test Distributed Without FDA Clearance
FDA (Devices) · 2026-05-13
Same hazard · unauthorized distribution
See all →- ModerateOne Step UTI in vitro diagnostic test recalled for missing FDA approval
FDA (Devices) · 2026-05-13
- ModeratePluslife SARS-CoV-2 Card Test Kits Recalled for Lack of FDA Authorization
FDA (Devices) · 2025-06-25
- HighStreptococcal A Rapid Test Kits Recalled for Unauthorized Distribution
FDA (Devices) · 2024-06-19
- HighStreptococcal A Rapid Test Kits Recalled for Unauthorized Distribution
FDA (Devices) · 2024-06-19
- ModerateStreptococcal A Rapid Test Kits Recalled for Unauthorized At-Home Distribution
FDA (Devices) · 2024-06-19